Researchers analyzed 17 different diagnostic tools across 10 studies to see how artificial intelligence (AI) performs when identifying melanoma. The study looked at both standalone AI systems and cases where AI assisted a human clinician in analyzing skin images.
The results showed that while AI can be used for diagnosis, it does not have a clear advantage over traditional dermoscopy. When AI worked alone, it showed varying levels of sensitivity and specificity. When AI was used to assist a human clinician, the sensitivity reached 1.000, but this specific data came from only one diagnostic arm.
Because there is so much variation between different AI programs and settings, these findings are currently considered hypothesis-generating. This means the results suggest interesting possibilities for the future but do not yet provide enough evidence to change how doctors treat patients today. More research is needed before AI can be recommended as a standard replacement for current methods.
Common questions
Is AI better than a doctor at spotting skin cancer?
The study found no clear clinical advantage of autonomous AI over traditional dermoscopic assessment. While an AI-assisted clinician reached a sensitivity of 1.000, this data came from only one diagnostic arm and is considered hypothesis-generating rather than a reason to change current medical practices immediately.
How accurate is AI when used alone to find melanoma?
When used alone, the sensitivity of AI ranged from 0.164 to 0.968 and specificity ranged from 0.374 to 0.983. Because there is substantial variability across different algorithms, these results vary significantly depending on the specific system being used.
Can AI help doctors identify skin cancer more effectively?
The study compared AI-assisted clinicians to standard dermoscopy. While the data for assisted clinicians showed high sensitivity, the evidence is limited to a single diagnostic arm. More research is needed before these tools can be recommended as a standard part of clinical practice.
